Comparative assessment of methods for the fusion transcripts detection from RNA-Seq data
- PMID: 26862001
- PMCID: PMC4748267
- DOI: 10.1038/srep21597
Comparative assessment of methods for the fusion transcripts detection from RNA-Seq data
Abstract
RNA-Seq made possible the global identification of fusion transcripts, i.e. "chimeric RNAs". Even though various software packages have been developed to serve this purpose, they behave differently in different datasets provided by different developers. It is important for both users, and developers to have an unbiased assessment of the performance of existing fusion detection tools. Toward this goal, we compared the performance of 12 well-known fusion detection software packages. We evaluated the sensitivity, false discovery rate, computing time, and memory usage of these tools in four different datasets (positive, negative, mixed, and test). We conclude that some tools are better than others in terms of sensitivity, positive prediction value, time consumption and memory usage. We also observed small overlaps of the fusions detected by different tools in the real dataset (test dataset). This could be due to false discoveries by various tools, but could also be due to the reason that none of the tools are inclusive. We have found that the performance of the tools depends on the quality, read length, and number of reads of the RNA-Seq data. We recommend that users choose the proper tools for their purpose based on the properties of their RNA-Seq data.
Figures
References
-
- Mortazavi A., Williams B. A., McCue K., Schaeffer L. & Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–8 (2008). - PubMed
-
- Jividen K. & Li H. Chimeric RNAs generated by intergenic splicing in normal and cancer cells. Gene. Chromosome. Canc. 53, 963–71 (2014). - PubMed
-
- Asmann Y. W. et al. Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer. Cancer Res. 72, 1921–8 (2012). - PubMed
-
- Salagierski M. & Schalken J. A. Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion. J. Urol. 187, 795–801 (2012). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
